Non-Coding Mutations Cause Enhancer Targeting Resulting in Protein Synthesis Dysregulation During B-Cell Lymphoma Progression
Demographics (3)
- AGE_ONSET - Disease onset age (phv00531460.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00531466.v1.p1)
- SEX - Biological sex (phv00531456.v1.p1)
Other (13)
- ANALYTE_TYPE - Analyte Type (phv00531463.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00531462.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00531455.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00531465.v1.p1)
- IS_TUMOR - Tumor status (phv00531464.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00531467.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00531468.v1.p1)
- SAMPLE_ID - Sample ID (phv00531461.v1.p1)
- SAMPLE_ID - Sample ID (phv00531458.v1.p1)
- SUBJECT_ID - Subject ID (phv00531454.v1.p1)
- SUBJECT_ID - Subject ID (phv00531457.v1.p1)
- SUBJECT_ID - Subject ID (phv00531459.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00531469.v1.p1)